Pharmacopeial reference standards for peptides: what they are and what they cost

Primary and secondary standards

ICH Q7 defines a primary reference standard as a substance shown by an extensive set of analytical tests to be authentic, high-purity material. It can come from an officially recognised source, independent synthesis, high-purity production material, or further purification. A secondary reference standard is a substance of established quality and purity, shown by comparison with a primary standard, and used for routine analysis. [1]

Q7 says primary standards from an officially recognised source are normally used without testing if stored as the supplier recommends, and their source, storage and use should be recorded. Where no official standard exists, an in-house primary standard should be established with full identity and purity testing. Each batch of secondary standard should be checked against the primary before first use and requalified periodically under a written protocol. [1] Whether a given pharmacopoeial standard counts as an officially recognised source for your work is a call for your quality unit; record the basis either way.

What the EDQM catalogue listed on 30 October 2026

EDQM sells European Pharmacopoeia chemical reference substances (CRS) through an online catalogue that shows the current batch, the quantity per unit and the price. [2] [3] [4] We searched it for several peptide names. Most peptide CRS were EUR 90 per sales unit; oxytocin CRS was EUR 110. The oxytocin and glucagon detail pages added a EUR 2.50 handling fee per sales unit. [5] [6] Shipping charges were not shown on the pages we could read, and EDQM's terms of sale document would not open for us, so budget for a delivery charge you will see at order.

Cost per milligram in the table divides price by the unit quantity printed in the catalogue. The value assigned to a standard is stated on its leaflet, not in the catalogue, so treat the per-milligram column as a rough comparison of pack sizes only.

Details on the product page that affect cost

Storage and shipping: both detail pages we opened specify long-term storage at minus 20 degrees C and dispatch on ice. [5] [6] A lab without reliable frozen storage will waste standards.

Batch validity: the oxytocin page showed batch 9 as current and batch 8 valid until 31 March 2027. [5] Standards are replaced by new batches, and a batch validity statement is what you file to show the one you used was valid on the date of analysis.

Purchase limits and availability: the glucagon page carried a sales restriction of 3 sales units every 30 days and said the item will be available in November 2026. [6] Order early if a project depends on a standard with a restriction.

Intended use: each page names the monographs the standard is used in. [5] [6] A CRS is established for the pharmacopoeial methods; using it to calibrate a different in-house method is a decision you have to justify yourself.

What we could not verify from USP

USP's reference standards pages and online store returned an access error when we tried to read them on 30 October 2026, so this guide gives no USP prices, unit sizes or catalogue numbers. If your methods follow USP monographs, check the USP store directly for the current lot and price and add it to the scenario below in place of the EDQM figure.

Yearly cost scenario: anchoring checks to a standard or relying on COAs

Scenario, with invented lab assumptions: a lab receives four lots a year of a peptide that has an EDQM CRS, and wants an independent check on each lot.

Route A, in-house comparison against a pharmacopeial standard. If one CRS unit is used per two lots, that is two units a year: 2 x (EUR 90 + EUR 2.50) = EUR 185, plus delivery and the lab's own instrument and analyst time. [4] [6] This gives a quantitative comparison with an officially recognised standard, but only if the lab already runs a suitable method.

Route B, rely on the supplier COA and send each lot out for an identity check. Ohio State's mass spectrometry facility listed accurate mass at USD 110 per sample for external academic users and USD 190 for industry users, effective 1 July 2025. [8] Four lots cost USD 440 or USD 760 a year. That confirms identity by mass, not purity or content, so it answers a narrower question than Route A.

Route C, a secondary standard. Qualify one larger in-house lot against the CRS once, then use it routinely and requalify on a schedule, as ICH Q7 describes. [1] This uses fewer CRS units per year but adds the qualification work and records.

When a pharmacopeial standard is worth buying

Buy one when a monograph method exists for your peptide and your results will be compared with others or reviewed. Skip it when no pharmacopeial standard exists for your sequence, which is the case for many research peptides; then the choice is between an in-house primary standard and relying on supplier documentation, covered in the site's traceability guide.